glp-1- GLP-1 Medications – Community Education *These statements have not been evaluated by the Food and Drug Administration (FDA) GLP-1 Drug Side Effects May
Description
Our findings expand the rapidly growing body of clinical research evaluating the role of GLP-1 receptor agonists in SUDs.256171856 Consistent with mechanistic evidence, our results show that GLP-1 receptor agonist related agonism may prevent addiction phenotypes across all major drug classes (reduced incident SUD across alcohol, cannabis, nicotine, cocaine, and opioids) and provide clinically meaningful harm reduction among people with an established SUD (fewer SUD related deaths and other adverse events)

The global GLP-1 receptor agonist market is rapidly expanding due to the rising prevalence of type 2 diabetes and obesity, which have become major public health concerns

QD, daily

Hum Reprod Update 2019

Nausea is the most commonly reported side effect, and antiemetic or prokinetic agents may be recommended for short-term use when it is severe or persistent
